STOCK TITAN

Neuberger Berman High Yield Strategies SEC Filings

NHS NYSE

Welcome to our dedicated page for Neuberger Berman High Yield Strategies SEC filings (Ticker: NHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Neuberger Berman High Yield Strategies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Neuberger Berman High Yield Strategies's regulatory disclosures and financial reporting.

Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. Schedule 13G discloses that Sit Investment Associates, Inc. and its subsidiary Sit Fixed Income Advisors II, LLC report shared voting and dispositive power over 5,447,450 shares of Common Stock (CUSIP 64128C106), representing 13.0% of the class. The filing bases percentages on 41,855,793 shares outstanding as of October 31, 2025 and notes adjustment for a rights offering dated April 15, 2026. The advisers state the shares are held in client accounts and disclaim beneficial ownership pursuant to Rule 13d-4.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. portfolio manager Chris Kocinski exercised subscription rights to acquire additional Common Stock. On April 15, 2026, he exercised Rights into 7,000 shares of Common Stock at a final subscription price of $6.50 per share, bringing his direct holdings to 28,000 shares.

The exercised position originated from 21,000 transferable subscription rights, each allowing the purchase of one new share of Common Stock for every three Rights held, as part of a rights offering made to common stockholders of record on March 23, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc.'s portfolio manager Joseph Lind acquired additional common shares by fully exercising transferable subscription rights from the fund’s rights offering. He exercised rights to obtain 12,833 shares at a final subscription price of $6.50 per share, bringing his direct holdings to 45,333 shares.

The rights were issued one-for-one to common stockholders of record as of March 23, 2026, and allowed holders to buy one new share for every three rights. Lind also subscribed for extra shares through the over-subscription privilege, with allocations determined after the April 15, 2026 subscription period expired.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. filed Post‑Effective Amendment No. 3 to its Form N-2 pursuant to Rule 462(d) to file exhibits; the amendment becomes effective immediately upon filing. The filing consists primarily of an index of exhibits and incorporation-by-reference statements.

The filing includes a Calculation of Filing Fee totaling $604,965, and reports the number of record holders as of February 1, 2026: 14 record holders for Common Stock and 1 for Preferred Stock (MRPS Series D). The fund restates routine undertakings, including a suspension condition if net asset value moves beyond specified thresholds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. is conducting a transferable rights offering to issue 10,463,948 shares of Common Stock upon exercise of Rights. One Right will be issued per outstanding share on the Record Date of March 23, 2026; three Rights are required to purchase one new share (1-for-3). The Rights expire at 5:00 PM Eastern on April 15, 2026 unless extended and are expected to trade under the symbol NHS RT.

The estimated Subscription Price shown is $6.84 (based on a 95% formula), with estimated gross proceeds of $71,573,404 and estimated net proceeds of approximately $68,418,335 after an estimated $650,000 of offering expenses and a Dealer Manager fee equal to 3.50% of the Subscription Price. Rights exercised are irrevocable; shares issued will not be record date stock for the Fund’s April 30, 2026 monthly distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. filed Post-Effective Amendment No. 2 to its Form N-2 under Rule 462(d) to furnish and file exhibits to its registration statement. The amendment becomes effective immediately upon filing and incorporates prior registration statement content by reference. The filing includes an exhibit index, a Calculation of Filing Fee Tables cross-reference, a Plan of Distribution incorporation by reference, an itemized schedule of expected issuance expenses totaling $604,965, and the number of record holders as of February 1, 2026 (14 record holders of common stock; 1 record holder of MRPS Series D). The amendment also restates the Fund’s undertakings, indemnification provisions, and identifies the locations of accounts and records.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. files a base prospectus registering $167,633,695 of common stock and transferable subscription rights to issue shares and/or rights in one or more offerings. The Fund's NAV per share was $7.25 and the last reported NYSE American sale price was $7.58 (a 4.55% premium) as of February 19, 2026.

The Fund had 31,386,322 shares outstanding as of February 19, 2026. As of October 31, 2025, the Fund reported loans of $61,000,000 and Mandatory Redeemable Preferred Shares, Series D with an aggregate liquidation preference of $40,000,000, representing a total leverage ratio of 30.2%; the Series D MRPS mature on September 29, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. received an updated ownership report on its common shares from First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation. The group reports beneficial ownership of 5,725,238 shares, representing 22.08% of the fund’s common stock.

The reporting persons have no sole or shared voting power over these shares but report shared dispositive power over all 5,725,238 shares. The position largely reflects holdings in unit investment trusts sponsored by First Trust Portfolios L.P., plus other investment vehicles and accounts advised by First Trust Advisors L.P.

The filing states that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the fund. Each reporting entity disclaims beneficial ownership of the shares identified.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Registrant submitted a Form N-CEN annual report template containing structured responses and partial data entries for an investment company identified by symbol NHS. The filing includes discrete line items for brokerage activity: aggregate brokerage commissions paid of $200 and affiliated broker‑dealer commissions of $0.

The form lists multiple Principal Transactions line items showing transaction values such as $90,891,725.81 and $302,802,399.48 among other per‑dealer amounts. Several sections remain as placeholders or N/A (for example, securities lending monthly averages marked N/A), and identifying fields (CIK, Fund name, addresses) are blank in the excerpt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. received an initial insider ownership report from portfolio manager Steven Richard Ruh. The Form 3 states that, as of 12/31/2025, no securities of the fund are beneficially owned. The filing is administrative in nature and does not report any purchases, sales, or derivative positions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Neuberger Berman High Yield Strategies (NHS) SEC filings are available on StockTitan?

StockTitan tracks 14 SEC filings for Neuberger Berman High Yield Strategies (NHS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Neuberger Berman High Yield Strategies (NHS)?

The most recent SEC filing for Neuberger Berman High Yield Strategies (NHS) was filed on May 5, 2026.